Filter
3760
Filtered Results: 3760
Text search:
drug
safety
Featured
Recommendations
404
New Publications
1037
Language
Document type
No document type
2169
Guidelines
592
Studies & Reports
519
Manuals
190
Strategic & Response Plan
132
Fact sheets
60
Training Material
53
Situation Updates
14
Infographics
11
Resource Platforms
8
Brochures
7
Online Courses
4
App
1
Countries / Regions
India
220
Kenya
112
South Africa
97
Global
96
Ethiopia
84
Uganda
81
Nigeria
75
Western and Central Europe
69
Nepal
65
Sierra Leone
64
Liberia
61
Tanzania
58
Myanmar / Burma
56
Zambia
54
Malawi
52
Bangladesh
51
Latin America and the Carribbean
47
Ghana
46
Africa
42
Rwanda
38
Philippines
37
Namibia
35
Zimbabwe
29
Eastern Europe
26
Cambodia
24
Ukraine
23
Lesotho
23
Russia
23
Syria
21
Asia
21
South–East Asia Region
21
Brazil
18
Germany
17
Botswana
17
Indonesia
17
Congo, Democratic Republic of
15
South Sudan
14
USA
13
Middle East and North Africa
13
Eastern Europe and Central Asia
13
West and Central Africa
12
East and Southern Africa
11
Eswatini/ Swaziland
11
Chile
10
Mozambique
10
Cameroon
9
Burkina Faso
9
Haiti
9
Tajikistan
8
Albania
8
Guinea
8
Pakistan
8
Senegal
7
Afghanistan
7
Vietnam
7
Colombia
6
Thailand
6
Venezuela
6
Western Pacific Region
6
Yemen
6
Laos
5
Sudan
5
Argentina
4
Georgia
4
Angola
4
Iraq
4
Turkey
3
China
3
Peru
3
Guinea-Bissau
3
Paraguay
3
United Kingdom
3
Spain
3
Moldova
3
Libya
3
Bhutan
3
Somalia
3
North Macedonia
2
Switzerland
2
Timor Leste/ East Timor
2
El Salvador
2
Benin
2
Canada
2
Kyrgyzstan
2
Uzbekistan
2
Jordan
2
North America
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Sri Lanka
2
Palestine
2
Central African Republic
2
Mali
2
Madagascar
2
Mexico
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Fiji
1
Singapore
1
Estonia
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Portugal
1
Bolivia
1
Papua New Guinea
1
Romania
1
Poland
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
1429
Clinical Guidelines
386
Public Health
196
Women & Child Health
180
Key Resources
143
Capacity Building
66
Pharmacy & Technologies
52
Toolboxes
HIV
356
Mental Health
335
TB
278
AMR
227
COVID-19
224
Pharmacy
167
NTDs
128
Caregiver
93
Ebola & Marburg
81
Rapid Response
80
NCDs
64
Planetary Health
60
Refugee
52
Conflict
46
Global Health Education
42
Disability
33
Specific Hazards
20
Natural Hazards
20
Cholera
18
Zika
16
Polio
15
Health Financing Toolbox
13
Social Ethics
7
Malaria
3
The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of the second tripartite self-assessment survey. It has ...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
Commissioned by Plan International the report draws on data from research conducted in Bangladesh in April 2018. It explores how adolescent girls within two age brackets (10-14 and 15-19) understand the unique impact the crisis has upon them, and how they have responded to the challenges they face.<...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
Managing Sexual Violence against Aid Workers aims to support aid agencies in preventing, being prepared for and responding to incidents of sexual violence against their staff. It is intended as a good practice guide to help strengthen existing processes and support organisations as they set up their...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
The document provides detailed guidelines for the production, formulation, and implementation of oral rehydration salts (ORS) to combat dehydration caused by diarrhoea, particularly in children. It focuses on the composition, quality standards, and packaging requirements of ORS, aiming to support na...
This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections:
Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of ...
